Saiyad Sarkar, M.D.

Temi is a board-certified Family Nurse Practitioner through the American Nursing Credential Center (ANCC). Her background is in Community and Public Health nursing. As a Nurse practitioner, she served in many health care roles with a focus on Primary Care, Acute/Critical/Urgent Care, Pulmonary health and Sleep health. As a Nurse Practitioner, the dream is to provide healthcare in wholeness for people using a holistic, and respectable approach, while promoting affordable healthcare to the general public through telemedicine. Temi is promoting health care delivery through video chat, phone, text, and email in the comfort of your home, office, or leisure. TEMITOPE FOWORA MS, GHC APRN FNP-BC Family Nurse Practitioner

Dr. Parikh received his medical degree from Seth G.S. Medical College and KEM Hospital in Mumbai, India and subsequently completed his Nephrology fellowship and a PhD in Clinical Investigation at the University of Colorado Health Sciences Center.Dr. Parikh’s research focuses on the translation and validation of novel biomarkers for the diagnosis and prognosis of acute kidney injury. Progress in kidney diseases has been hamstrung by significant heterogeneity within the current disease definitions, which are largely based on serum creatinine. Dr. Parikh’s research has addressed this critical challenge by developing biomarkers of renal tubular injury, repair, and inflammation to dissect this heterogeneity. He has assembled multicenter longitudinal prospective cohorts for translational research studies across several clinical settings of acute kidney injury and chronic kidney disease for the efficient translation of novel biomarkers.His research is dedicated to the process of applying discoveries generated in the laboratory and in preclinical experiments, the development of clinical studies, and the design of clinical trials. Dr. Parikh’s studies have refined the clinical definition in perioperative acute kidney injury and hepatorenal syndrome, developed strategies to reduce kidney discard in deceased donor transplantation, and advanced regulatory approvals of kidney injury biomarkers. He has also developed biomarkers to identify rapid progressors of early diabetic kidney disease before derangements in serum creatinine. Dr. Parikh’s research goal is to translate our understanding of pathophysiological mechanisms into clinical practice and improve the outcomes in patients with kidney disease.Dr. Parikh has also been the recipient of numerous honors, including the 2017 Young Investigator Award from the American Society of Nephrology.